Drug makers Eli Lilly and Merck have disclosed separate requests from the U.S. Justice Department for information related to drug pricing—the latest sign of increased scrutiny of the industry’s pricing practices.
from WSJ.com: US Business http://ift.tt/1PsPDPm
via IFTTT
No comments:
Post a Comment